Identification of Predictive Gene Markers for Multipotent Stromal Cell Proliferation

Stem Cells and Development

Volumn 25, Issue 11, 2016, Pages 861-873

  Bellayr, Ian H ^a   Marklein, Ross A ^a   Lo Surdo, Jessica L ^a   Bauer, Steven R ^a   Puri, Raj K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CELL CYCLE PROTEIN 20; CELL MARKER; CYCLIN A2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; HIGH MOBILITY GROUP B3 PROTEIN; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 3; POLO LIKE KINASE 1; UNCLASSIFIED DRUG; GENETIC MARKER;

ADULT; ARTICLE; BIRC5 GENE; BONE MARROW STROMA CELL; CDK1 GENE; CELL PROLIFERATION; CENPF GENE; CKS1B GENE; CKS2 GENE; CONTROLLED STUDY; FEMALE; FETUS; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HAS2 GENE; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; KIF20B GENE; KPNA2 GENE; KRT18 GENE; MALE; MARKER GENE; MICROARRAY ANALYSIS; MIDDLE AGED; MULTIPOTENT STEM CELL; PBK GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SGOL2 GENE; SMC4 GENE; SPC25 GENE; SPOCK1 GENE; TPX2 GENE; UBE2S GENE; YOUNG ADULT; CYTOLOGY; DNA MICROARRAY; GENETIC MARKER; METABOLISM; PRINCIPAL COMPONENT ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; REPRODUCIBILITY; STROMA CELL;

ADULT; CELL PROLIFERATION; FEMALE; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; MULTIPOTENT STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; STROMAL CELLS; YOUNG ADULT;

EID: 84971539252     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2015.0374     Document Type: Article

References (66)

1. Baboolal TG, SC Mastbergen, E Jones, SJ Calder, FP Lafeber and D McGonagle. (2015). Synovial fluid hyaluronan mediates MSC attachment to cartilage, a potential novel mechanism contributing to cartilage repair in osteoarthritis using knee joint distraction. Ann Rheum Dis 0:8.
2. Harada Y, T Nakasa, EE Mahmoud, G Kamei, N Adachi, M Deie and M Ochi. (2015). Combination therapy with intraarticular injection of mesenchymal stem cells and articulated joint distraction for repair of a chronic osteochondral defect in the rabbit. J Orthop Res 33:1466-1473.
3. Gao Y, A Yao, W Zhang, S Lu, Y Yu, L Deng, A Yin, Y Xia, B Sun and X Wang. (2010). Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice. Oncogene 29:2784-2794.
4. Kai D, QL Wang, HJ Wang, MP Prabhakaran, Y Zhang, YZ Tan and S Ramakrishna. (2014). Stem cell-loaded nanofibrous patch promotes the regeneration of infarcted myocardium with functional improvement in rat model. Acta Biomater 10:2727-2738.
5. Khakoo AY, S Pati, SA Anderson, W Reid, MF Elshal, Rovira, II, AT Nguyen, D Malide, CA Combs, et al. (2006). Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203: 1235-1247.
6. Li ZY, CQ Wang, G Lu, XY Pan and KL Xu. (2014). Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model. Cell Biochem Biophys 70:115-122.
7. Nakamizo A, F Marini, T Amano, A Khan, M Studeny, J Gumin, J Chen, S Hentschel, G Vecil, et al. (2005). Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318.
8. Robles JD, YP Liu, J Cao, Z Xiang, Y Cai, M Manio, EH Tang and GC Chan. (2015). Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models. Exp Hematol Oncol 4:13.
9. Tao B, M Cui, C Wang, S Ma, F Wu, F Yi, X Qin, J Liu, H Wang, et al. (2015). Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart. Theranostics 5:196-205.
10. Abumaree M, M Al Jumah, RA Pace and B Kalionis. (2012). Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 8:375-392.
11. Baraniak PR and TC McDevitt. (2010). Stem cell paracrine actions and tissue regeneration. Regen Med 5:121-143.
12. Muraglia A, R Cancedda and R Quarto. (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113 (Pt 7):1161-1166.
13. Jin HJ, YK Bae, M Kim, SJ Kwon, HB Jeon, SJ Choi, SW Kim, YS Yang, W Oh and JW Chang. (2013). Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci 14:17986-18001.
14. Okumachi E, SY Lee, T Niikura, T Iwakura, Y Dogaki, T Waki, S Takahara, T Ueha, Y Sakai, R Kuroda and M Kurosaka. (2015). Comparative analysis of rat mesenchymal stem cells derived from slow and fast skeletal muscle in vitro. Int Orthop 39:569-576.
15. Ryu HH, BJ Kang, SS Park, Y Kim, GJ Sung, HM Woo, WH Kim and OK Kweon. (2012). Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J Vet Med Sci 74:1617-1630.
16. Mendicino M, AM Bailey, K Wonnacott, RK Puri and SR Bauer. (2014). MSC-based product characterization for clinical trials: An FDA perspective. Cell Stem Cell 14: 141-145.
17. Mentink A, M Hulsman, N Groen, R Licht, KJ Dechering, J van der Stok, HA Alves, WJ Dhert, EP van Someren, et al. (2013). Predicting the therapeutic efficacy of MSC in bone tissue engineering using the molecular marker CADM1. Biomaterials 34:4592-4601.
18. Platt MO, CL Wilder, A Wells, LG Griffith and DA Lauffenburger. (2009). Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: Tissue-specific stem cells. Stem Cells 27: 2804-2814.
19. Williams R, B Schuldt and FJ Muller. (2011). A guide to stem cell identification: progress and challenges in systemwide predictive testing with complex biomarkers. Bioessays 33:880-890.
20. Ren J, DF Stroncek, Y Zhao, P Jin, L Castiello, S Civini, H Wang, J Feng, K Tran, et al. (2013). Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence. Stem Cell Res 11:1060-1073.
21. Gruvberger-Saal SK, HE Cunliffe, KM Carr and IA Hedenfalk. (2006). Microarrays in breast cancer research and clinical practice-the future lies ahead. Endocr Relat Cancer 13:1017-1031.
22. Gruvberger-Saal SK, P Eden, M Ringner, B Baldetorp, G Chebil, A Borg, M Ferno, C Peterson and PS Meltzer. (2004). Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles. Mol Cancer Ther 3:161-168.
23. Lo Surdo JL, BA Millis and SR Bauer. (2013). Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells. Cytotherapy 15: 1527-1540.
24. Mindaye ST, M Ra, JL Lo Surdo, SR Bauer and MA Alterman. (2013). Global proteomic signature of undifferentiated human bone marrow stromal cells: evidence for donor-to-donor proteome heterogeneity. Stem Cell Res 11: 793-805.
25. Shao K, C Koch, MK Gupta, Q Lin, M Lenz, S Laufs, B Denecke, M Schmidt, M Linke, et al. (2013). Induced pluripotent mesenchymal stromal cell clones retain donorderived differences in DNA methylation profiles. Mol Ther 21:240-250.
26. Walter MN, N Kohli, N Khan, T Major, H Fuller, KT Wright, JH Kuiper and WE Johnson. (2015). Human mesenchymal stem cells stimulate EaHy926 endothelial cell migration: combined proteomic and in vitro analysis of the influence of donor-donor variability. J Stem Cells Regen Med 11:18-24.
27. Bellayr IH, JG Catalano, S Lababidi, AX Yang, JL Lo Surdo, SR Bauer and RK Puri. (2014). Gene markers of cellular aging in human multipotent stromal cells in culture. Stem Cell Res Ther 5:59.
28. Lo Surdo J and SR Bauer. (2012). Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells. Tissue Eng Part C Methods 18: 877-889.
29. Mindaye ST, M Ra, J Lo Surdo, SR Bauer and MA Alterman. (2013). Improved proteomic profiling of the cell surface of culture-expanded human bone marrow multipotent stromal cells. J Proteomics 78:1-14.
30. Vandesompele J, K De Preter, F Pattyn, B Poppe, N Van Roy, A De Paepe and F Speleman. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:12.
31. Benjamini Y and Y Hochberg. (1995). Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Series B-Methodol 57: 289-300.
32. Lynch PJ, EE Thompson, K McGinnis, YI Rovira Gonzalez, J Lo Surdo, SR Bauer and DA Hursh. (2015). Chromatin changes at the PPAR-gamma2 promoter during bone marrow-derived multipotent stromal cell culture correlate with loss of gene activation potential. Stem Cells 33:2169-2181.
33. Nazarov C, J Lo Surdo, SR Bauer and CH Wei. (2013). Assessment of immunosuppressive activity of human mesenchymal stem cells using murine antigen specific CD4 and CD8 T cells in vitro. Stem Cell Res Ther 4:128.
34. Marklein RA, JL Lo Surdo, IH Bellayr, SA Godil, RK Puri and SR Bauer. (2016). High content imaging of early morphological signatures predicts long term mineralization capacity of human mesenchymal stem cells upon osteogenic induction. Stem Cells 34:13.
35. Bernardo ME, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, D Montagna, R Maccario, R Villa, et al. (2007). Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142-9149.
36. Eom YW, JE Oh, JI Lee, SK Baik, KJ Rhee, HC Shin, YM Kim, CM Ahn, JH Kong, HS Kim and KY Shim. (2014). The role of growth factors in maintenance of stemness in bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 445:16-22.
37. Hwang SH, SH Park, J Choi, DC Lee, JH Oh, UC Yeo, SW Kim and DI Sun. (2013). Age-related characteristics of multipotent human nasal inferior turbinate-derived mesenchymal stem cells. PLoS One 8:e74330.
38. Izadpanah R, D Kaushal, C Kriedt, F Tsien, B Patel, J Dufour and BA Bunnell. (2008). Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res 68:4229-4238.
39. Li Y, X Xu, L Wang, G Liu, Y Li, X Wu, Y Jing, H Li and G Wang. (2015). Senescent mesenchymal stem cells promote colorectal cancer cells growth via galectin-3 expression. Cell Biosci 5:21.
40. Wagner W, P Horn, M Castoldi, A Diehlmann, S Bork, R Saffrich, V Benes, J Blake, S Pfister, V Eckstein and AD Ho. (2008). Replicative senescence of mesenchymal stem cells: A continuous and organized process. PLoS One 3: e2213.
41. Yu Y, YS Park, HS Kim, HY Kim, YM Jin, SC Jung, KH Ryu and I Jo. (2014). Characterization of long-term in vitro culture-related alterations of human tonsil-derived mesenchymal stem cells: role for CCN1 in replicative senescenceassociated increase in osteogenic differentiation. J Anat 225: 510-518.
42. Alushin GM, V Musinipally, D Matson, J Tooley, PT Stukenberg and E Nogales. (2012). Multimodal microtubule binding by the Ndc80 kinetochore complex. Nat Struct Mol Biol 19:1161-1167.
43. Ayeni JO, R Varadarajan, O Mukherjee, DT Stuart, F Sprenger, M Srayko and SD Campbell. (2014). Dual phosphorylation of cdk1 coordinates cell proliferation with key developmental processes in Drosophila. Genetics 196: 197-210.
44. Bendris N, A Loukil, C Cheung, N Arsic, C Rebouissou, R Hipskind, M Peter, B Lemmers and JM Blanchard. (2012). Cyclin A2: A genuine cell cycle regulator? Biomol Concepts 3:535-543.
45. Chen Z, Y Yu, D Fu, Z Li, X Niu, M Liao and S Lu. (2010). Functional roles of PC-PLC and Cdc20 in the cell cycle, proliferation, and apoptosis. Cell Biochem Funct 28:249-257.
46. Dou X, J Wei, A Sun, G Shao, C Childress, W Yang and Q Lin. (2015). PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation. Cancer Cell Int 15:27.
47. Ito Y, H Yoshida, F Matsuzuka, N Matsuura, Y Nakamura, H Nakamine, K Kakudo, K Kuma and A Miyauchi. (2004). Polo-like kinase 1 (PLK1) expression is associated with cell proliferative activity and cdc2 expression in malignant lymphoma of the thyroid. Anticancer Res 24: 259-263.
48. Wang C, X Zheng, C Shen and Y Shi. (2012). MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. J Exp Clin Cancer Res 31:58.
49. Brown NR, S Korolchuk, MP Martin, WA Stanley, R Moukhametzianov, ME Noble and JA Endicott. (2015). CDK1 structures reveal conserved and unique features of the essential cell cycle CDK. Nat Commun 6:6769.
50. Jernman J, MJ Valimaki, J Hagstrom, J Louhimo, H Haapasalo, J Arola and C Haglund. (2014). Cyclin a predicts metastatic potential of rectal neuroendocrine tumors. Hum Pathol 45:1605-1609.
51. Baumann C, R Korner, K Hofmann and EA Nigg. (2007). PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint. Cell 128:101-114.
52. Mao DD, AD Gujar, T Mahlokozera, I Chen, Y Pan, J Luo, T Brost, EA Thompson, A Turski, et al. (2015). A CDC20-APC/SOX2 signaling axis regulates human glioblastoma stem-like cells. Cell Rep 11:1809-1821.
53. McCleland ML, MJ Kallio, GA Barrett-Wilt, CA Kestner, J Shabanowitz, DF Hunt, GJ Gorbsky and PT Stukenberg. (2004). The vertebrate Ndc80 complex contains Spc24 and Spc25 homologs, which are required to establish andmaintain kinetochore-microtubule attachment. Curr Biol 14:131-137.
54. Shinde SR, NR Gangula, S Kavela, V Pandey and S Maddika. (2013). TOPK and PTEN participate in CHFR mediated mitotic checkpoint. Cell Signal 25:2511-2517.
55. Yano Y, T Otsuka, H Hirano, T Uenami, A Satomi, M Kuroyama, M Niinaka, T Yoneda, H Kimura, et al. (2015). Nuclear survivin expression in small cell lung cancer. Anticancer Res 35:2935-2939.
56. Danilewicz M, O Stasikowska-Kanicka and M Wagrowska-Danilewicz. (2015). Augmented immunoexpression of survivin correlates with parameters of aggressiveness in prostate cancer. Pol J Pathol 66:44-48.
57. Schimmer AD. (2004). Inhibitor of apoptosis proteins: Translating basic knowledge into clinical practice. Cancer Res 64:7183-7190.
58. Ayllon V and R O'Connor. (2007). PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene 26: 3451-3461.
59. Hoben G, Y Yan, N Iyer, P Newton, DA Hunter, AMMoore, SE Sakiyama-Elbert, MD Wood and SE Mackinnon. (2015). Comparison of acellular nerve allograft modification with Schwann cells or VEGF. Hand (N Y) 10:396-402.
60. Kern JS, S Loeckermann, A Fritsch, I Hausser, W Roth, TM Magin, C Mack, ML Muller, O Paul, P Ruther and L Bruckner-Tuderman. (2009). Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther 17:1605-1615.
61. Kuramoto G, S Takagi, K Ishitani, T Shimizu, T Okano and H Matsui. (2015). Preventive effect of oral mucosal epithelial cell sheets on intrauterine adhesions. Hum Reprod 30:406-416.
62. Mehnert JM, T Kisch and M Brandenburger. (2014). Coculture systems of human sweat gland derived stem cells and peripheral nerve cells: An in vitro approach for peripheral nerve regeneration. Cell Physiol Biochem 34:1027-1037.
63. Okuizumi T, H Tohyama, E Kondo and K Yasuda. (2004). The effect of cell-based therapy with autologous synovial fibroblasts activated by exogenous TGF-beta1 on the in situ frozen-thawed anterior cruciate ligament. J Orthop Sci 9:488-494.
64. Saito K, T Tamaki, M Hirata, H Hashimoto, K Nakazato, N Nakajima, A Kazuno, A Sakai, M Iida and K Okami. (2015). Reconstruction of multiple facial nerve branches using skeletal muscle-derived multipotent stem cell sheetpellet transplantation. PLoS One 10:e0138371.
65. Schinhan M, M Gruber, R Dorotka, M Pilz, D Stelzeneder, C Chiari, N Rossler, R Windhager and S Nehrer. (2013). Matrix-associated autologous chondrocyte transplantation in a compartmentalized early stage of osteoarthritis. Osteoarthritis Cartilage 21:217-225.
66. Carmen J, SR Burger, M McCaman and JA Rowley. (2012). Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development. Regen Med 7:85-100.